2,365.00
-30.00 (-1.25%)
| Penutupan Terdahulu | 2,395.00 |
| Buka | 2,382.86 |
| Jumlah Dagangan | 43,498 |
| Purata Dagangan (3B) | 146,302 |
| Modal Pasaran | 1,628,341,248 |
| Harga / Pendapatan (P/E TTM) | 81.55 |
| Harga / Pendapatan (P/E Ke hadapan) | 29.15 |
| Harga / Jualan (P/S) | 2.57 |
| Harga / Buku (P/B) | 3.61 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Sep 2025 - 8 Sep 2025 |
| Hasil Dividen (DY TTM) | 0.01% |
| Margin Keuntungan | -0.60% |
| Margin Operasi (TTM) | 10.23% |
| EPS Cair (TTM) | -0.060 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 0.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -88.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 57.63% |
| Nisbah Semasa (MRQ) | 1.94 |
| Aliran Tunai Operasi (OCF TTM) | 49.30 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 89.54 M |
| Pulangan Atas Aset (ROA TTM) | 3.81% |
| Pulangan Atas Ekuiti (ROE TTM) | -1.17% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (GB) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | GENUS PLC ORD 10P | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.75 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| GENUS PLC ORD 10P | 2 B | 0.01% | 81.55 | 3.61 |
| PHARMA MAR SA PHARMA MAR ORD SH | 16 B | 1.08% | 14.69 | - |
| ARROWHEAD PHARMACEUTICALS INC A | 4 B | - | - | - |
| BASILEA PHARMACEUTICA AG BASILE | 511 M | - | - | 6.18 |
| AVACTA GROUP PLC ORD 10P | 353 M | - | - | 2.35 |
| PROTHENA CORPORATION PLC PROTHE | 330 M | - | 7.53 | - |
|
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.75% |
| % Dimiliki oleh Institusi | 87.92% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |